Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
Sarcoidosis Vasc Diffuse Lung Dis
; 37(2): 234-238, 2020.
Article
in En
| MEDLINE
| ID: mdl-33093789
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phenylpropionates
/
Pulmonary Artery
/
Pyridazines
/
Sarcoidosis, Pulmonary
/
Phosphodiesterase 5 Inhibitors
/
Arterial Pressure
/
Endothelin A Receptor Antagonists
/
Tadalafil
/
Hypertension, Pulmonary
/
Antihypertensive Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Sarcoidosis Vasc Diffuse Lung Dis
Journal subject:
ALERGIA E IMUNOLOGIA
/
ANGIOLOGIA
Year:
2020
Document type:
Article
Country of publication:
Italy